IS5166A - Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýru - Google Patents
Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýruInfo
- Publication number
- IS5166A IS5166A IS5166A IS5166A IS5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A
- Authority
- IS
- Iceland
- Prior art keywords
- phenylpyrrolidin
- indole
- dichloro
- oxo
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
| PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5166A true IS5166A (is) | 1999-08-27 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5166A IS5166A (is) | 1997-03-05 | 1999-08-27 | Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýru |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (id) |
| JP (1) | JP2001513796A (id) |
| KR (1) | KR20000075907A (id) |
| CN (1) | CN1249750A (id) |
| AP (1) | AP9901637A0 (id) |
| AR (1) | AR011178A1 (id) |
| AU (1) | AU6825198A (id) |
| BG (1) | BG103779A (id) |
| BR (1) | BR9808305A (id) |
| CA (1) | CA2282851A1 (id) |
| CO (1) | CO4940415A1 (id) |
| EA (1) | EA199900710A1 (id) |
| EE (1) | EE9900387A (id) |
| GB (1) | GB9704498D0 (id) |
| HR (1) | HRP980114A2 (id) |
| HU (1) | HUP0002109A2 (id) |
| ID (1) | ID24207A (id) |
| IL (1) | IL131489A0 (id) |
| IS (1) | IS5166A (id) |
| NO (1) | NO994303L (id) |
| NZ (1) | NZ337315A (id) |
| OA (1) | OA11154A (id) |
| PE (1) | PE51399A1 (id) |
| PL (1) | PL335652A1 (id) |
| SK (1) | SK119699A3 (id) |
| TR (1) | TR199902117T2 (id) |
| WO (1) | WO1998039327A1 (id) |
| YU (1) | YU43499A (id) |
| ZA (1) | ZA981791B (id) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| MX393950B (es) | 2017-06-12 | 2025-03-24 | Glytech Llc | Composicion y metodo para el tratamiento de la depresion y psicosis en humanos |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Withdrawn
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Ceased
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000075907A (ko) | 2000-12-26 |
| CA2282851A1 (en) | 1998-09-11 |
| GB9704498D0 (en) | 1997-04-23 |
| AP9901637A0 (en) | 1999-09-30 |
| HUP0002109A2 (hu) | 2001-04-28 |
| CO4940415A1 (es) | 2000-07-24 |
| NO994303L (no) | 1999-11-03 |
| ZA981791B (en) | 1999-09-03 |
| PL335652A1 (en) | 2000-05-08 |
| IL131489A0 (en) | 2001-01-28 |
| AU6825198A (en) | 1998-09-22 |
| NO994303D0 (no) | 1999-09-03 |
| HRP980114A2 (en) | 1998-12-31 |
| NZ337315A (en) | 2001-02-23 |
| EA199900710A1 (ru) | 2000-04-24 |
| BG103779A (en) | 2000-06-30 |
| JP2001513796A (ja) | 2001-09-04 |
| EP0966463A1 (en) | 1999-12-29 |
| SK119699A3 (en) | 2000-05-16 |
| ID24207A (id) | 2000-07-13 |
| AR011178A1 (es) | 2000-08-02 |
| EE9900387A (et) | 2000-04-17 |
| YU43499A (sh) | 2000-12-28 |
| PE51399A1 (es) | 1999-06-07 |
| BR9808305A (pt) | 2000-05-16 |
| TR199902117T2 (xx) | 2000-03-21 |
| WO1998039327A1 (en) | 1998-09-11 |
| CN1249750A (zh) | 2000-04-05 |
| OA11154A (en) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0991641T3 (da) | Krystallinsk form af omeprazol-natriumsalt | |
| PT1077957E (pt) | Derivados do acido oxi-iminoalcanoico | |
| NO20005084D0 (no) | Heterosykliske glysyl <beta>-alanin derivater som vitronektinantagonister | |
| NO20013665L (no) | Kaliumsalt av (S)-omeprazol | |
| EE200000720A (et) | Uus 3-arüül-2-hüdroksüpropaanhappe derivaat (I) | |
| AR028280A1 (es) | Derivados de 2-amino-3-(alquil)-pirimidona | |
| DK1163207T3 (da) | Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin | |
| DE69900356D1 (de) | Nitro-Isoharnstoffderivate | |
| NO20003451D0 (no) | 2,3-substituerte indolforbindelser som cox-2 inhibitorer | |
| IS5772A (is) | Þalazín (phthalazine) afleiður af fosfódíesterasa4 lötum | |
| NO20013684D0 (no) | Substituerte fenetylaminderivater | |
| IS5562A (is) | Nýjar díhýdroxýhexanósýru afleiður | |
| ATE299876T1 (de) | Indolderivate | |
| IS5166A (is) | Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýru | |
| DK0975594T3 (da) | Fremgangsmåde til fremstilling af indolderivater | |
| IS6434A (is) | Nýjar indól afleiður | |
| NO20020306D0 (no) | Indolderivater | |
| NO20002904D0 (no) | (E)-3-[1-N-butyl-5-[2-(2-karboksylfenyl)metoksy-4-klorfenyl]- 1H-pyrazol-4-yl]-2-[(5-metoksy-2,3-dihydrobenzofuran-6-yl)methyl]- prop-2-ensyre monoagrininsalt | |
| NO994386D0 (no) | 2-substituerte benzoylcykloalkyl-1-karboksylsyrederivater | |
| IT1307734B1 (it) | Cartuccia per dialisi contenente bicarbonato di sodio. | |
| DK1140984T3 (da) | Selektive inhibitorer af MMP-12 | |
| HK1022899A (en) | Crystalline hydrated sodium salt of (e)-4, 6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid | |
| ATE414059T1 (de) | Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid | |
| DK0989113T3 (da) | Fremgangsmåde til fremstilling af 2-aminomalonsyrederivater |